New heart failure drug trial aims to ease breathing and save lives
NCT ID NCT07262723
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether levosimendan, a drug that strengthens heart contractions without increasing oxygen demand, can help people hospitalized with acute decompensated heart failure. About 332 adults will receive either levosimendan plus standard care or standard care alone. Researchers will track symptom improvement, side effects, and survival over 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Levosimendan
What this could lead to
If it works, this could provide a new treatment option for acute heart failure, improving symptoms and reducing hospital stays.
What could go wrong
This is a Phase 2/3 trial, so results are not yet proven. The drug may not show significant benefit over standard care, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE (ADHF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apollo Imperial Hospital & Max Hospital
Chittagong, 4202, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chattogram Maa-O-Shishu Hospital Medical College Hospital
Chittagong, 4100, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chittagong Medical College Hospital, Chattogram
Chittagong, 4000, Bangladesh
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cox's Bazar Medical College
Cox’s Bāzār, 4700, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
National Institute of Cardiovascular Diseases
Dhaka, 1207, Bangladesh
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
United Hospital Limited
Dhaka, 1212, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact